ArticleNeuro-oncology2019

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.

Mark W Kieran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.